These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
636 related items for PubMed ID: 12827560
1. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Kugelmas M, Spiegelman P, Osgood MJ, Young DA, Trotter JF, Steinberg T, Wachs ME, Bak T, Kam I, Everson GT. Liver Transpl; 2003 Jul; 9(7):727-32. PubMed ID: 12827560 [Abstract] [Full Text] [Related]
2. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Alabraba E, Nightingale P, Gunson B, Hubscher S, Olliff S, Mirza D, Neuberger J. Liver Transpl; 2009 Mar; 15(3):330-40. PubMed ID: 19243003 [Abstract] [Full Text] [Related]
3. Recurrence of primary sclerosing cholangitis in patients after liver transplantation. Ołdakowska-Jedynak U, Nowak M, Mucha K, Foroncewicz B, Nyckowski P, Zieniewicz K, Ziarkiewicz-Wróblewska B, Patkowski W, Górnicka B, Paczkowska A, Michałowicz B, Pilecki T, Pawlak J, Krawczyk M, Paczek L. Transplant Proc; 2006 Mar; 38(1):240-3. PubMed ID: 16504713 [Abstract] [Full Text] [Related]
4. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF. Transplantation; 2003 Jun 27; 75(12):1983-8. PubMed ID: 12829898 [Abstract] [Full Text] [Related]
5. Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kam I. Liver Transpl; 2008 Feb 27; 14(2):181-5. PubMed ID: 18236392 [Abstract] [Full Text] [Related]
6. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease. Wiesner RH. Best Pract Res Clin Gastroenterol; 2001 Aug 27; 15(4):667-80. PubMed ID: 11492975 [Abstract] [Full Text] [Related]
15. Childhood autoimmune liver disease: indications and outcome of liver transplantation. Chai PF, Lee WS, Brown RM, McPartland JL, Foster K, McKiernan PJ, Kelly DA. J Pediatr Gastroenterol Nutr; 2010 Mar 27; 50(3):295-302. PubMed ID: 20118802 [Abstract] [Full Text] [Related]
16. IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis. Zhang L, Lewis JT, Abraham SC, Smyrk TC, Leung S, Chari ST, Poterucha JJ, Rosen CB, Lohse CM, Katzmann JA, Wu TT. Am J Surg Pathol; 2010 Jan 27; 34(1):88-94. PubMed ID: 20035148 [Abstract] [Full Text] [Related]
17. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? Harrison RF, Davies MH, Neuberger JM, Hubscher SG. Hepatology; 1994 Aug 27; 20(2):356-61. PubMed ID: 8045496 [Abstract] [Full Text] [Related]
18. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease. Jørgensen KK, Lindström L, Cvancarova M, Karlsen TH, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM. Clin Gastroenterol Hepatol; 2013 May 27; 11(5):517-23. PubMed ID: 23333218 [Abstract] [Full Text] [Related]
19. Frequent overlap of active hepatitis in recurrent primary sclerosing cholangitis after living-donor liver transplantation relates to its rapidly progressive course. Miyagawa-Hayashino A, Egawa H, Yoshizawa A, Ueda Y, Ichida T, Ueno Y, Uemoto S, Harada K, Nakanuma Y. Hum Pathol; 2011 Sep 27; 42(9):1329-36. PubMed ID: 21334714 [Abstract] [Full Text] [Related]